Pod Insights Masters of Scale Rapid Response: Lessons of Omicron, w/Sir Jeremy Farrar, director of Wellcome Trust About this episode Sir Jeremy Farrar is UK’s pre-eminent scientific authority on Covid-19 and the chief executive at the research foundation Wellcome Trust. He joins Rapid Response to discuss the latest learnings of the Omicron variant – and offers a framework for reacting to the uncertainty. Farrar, whose research specializes in infectious diseases, also shares the two most important leadership lessons he’s learned during the pandemic: find time for yourself, and take warnings seriously. “Humanity often finds ways of going through some really bad periods to get to a good place. And I think we're going through a bad period at the moment,” Farrar says.
Read a transcript of this episode: https://mastersofscale.com https://mastersofscale.com/
Subscribe to the Masters of Scale weekly newsletter: https://mastersofscale.com/subscribe
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
Transcript 0:01 Speaker 00 We've all spent money on something that seemed incredible, but didn't live up to the hype. A kitchen gadget, a car. When it doesn't deliver, the disappointment is real. Marketers suffer from this too. Chasing metrics that look great, but don't translate into revenue. LinkedIn calls that bull spend. Invest in what matters and reach the right buyers with LinkedIn Ads. You can target by company, industry, job title, and more. LinkedIn Ads also generates the highest ROAS of all major ad networks. Spend $250 on your first campaign on LinkedIn Ads and get a $250 credit for the next one. Just go to LinkedIn.com/scale. That's LinkedIn.com/scale. Terms and conditions apply.
0:48 Speaker 00 The very best founders I know are brilliant at building systems. They connect teams, they remove bottlenecks, and they eliminate single points of failure. And yet, when it comes to their own wealth, most are running a disconnected stack. A tax accountant here and a state attorney there, a wealth manager who doesn't talk to either one of them. Creative Planning was built to fix exactly that. One integrated team of tax professionals, state planners, investment specialists, all coordinated by a dedicated wealth manager who sees your full financial picture and keeps every piece working together. Proactive tax efficiency, estate strategy, investments, all under one roof.
1:32 Speaker 00 Creative Planning, where wealth works together. Learn more at creativeplanning.com/mastersofscale.
1:41 Speaker 01 AI is full of possibilities. Enterprises run on realities. That's why Pega combines the world's most powerful AI with the governance, transparency, and control enterprises demand. So you can move faster, adapt faster, and scale AI with confidence. All the power of AI, none of the uncertainty. Learn more at Pega.com/AI.
2:07 Speaker 02 I have received hate mail, death threats by mail, by email, by social media. I contacted the security forces here when your microphone arrived and asked them to scan it and look at it properly before I opened it. The transmission of this Omicron variant is staggering. What is the most likely scenario for the next one, two, three years? But then what are the other possibilities? What do we need to prepare for that would really dramatically change the way we do business? It's not going away. We're not going to wake up on Tuesday morning and somebody will say the pandemic's over. It's not going to happen like that. It'll be a bumpy ride through 22 and into 23 and beyond.
2:54 Speaker 03 That's Sir Jeremy Farrar, the chief executive at the massive research foundation Wellcome Trust, and in recent years, the UK's preeminent scientific authority on COVID-19. Farrar is a doctor who spent decades in the trenches researching and fighting viruses from bird flu to SARS to Ebola. I'm Bob Safian, former editor of Fast Company, founder of the Flux Group, and host of Masters of Scale Rapid Response. I wanted to talk to Jeremy because with the Omicron variant raging, the pandemic is creating a fresh set of uncertainties. Farrar's been a steady source of advice since the initial Wuhan outbreak, a counselor to governments, individuals, and businesses. He offers a framework for reacting to this latest stage, and observations both cautionary
3:38 Speaker 03 and reassuring about what's to come. He also talks about how efforts at Welcome with its $50 billion endowment have been shifting, and his emphasis on sparking what he calls catalytic change through risky disruptive investments in scientific discovery. He also stresses that mental health is among the biggest risks the planet faces today, and that safeguarding his own psyche has been an essential lesson in leading through this crisis.
4:14 Speaker 03 I'm Bob Safian and I'm here with Sir Jeremy Farrar, the Director of Wellcome Trust, one of the world's largest NGOs dedicated to scientific research and impact. Jeremy's coming to us from London as I ask my questions from my home in Brooklyn. Jeremy, thanks for joining us.
4:32 Speaker 02 Yeah, great pleasure.
4:34 Speaker 03 So in recent times, you've had to juggle a variety of leadership challenges at the helm of Welcome's growing operations, as a world-renowned infectious diseases expert, as a spokesperson and trusted public voice during the pandemic. You also managed to author a book during this time, Spike, about the outbreak of the pandemic and how it was dealt with. Many topics for us to cover, but I have to start with Omicron. This latest variant has many of us rethinking our approaches yet again as individuals, as businesses. The COVID positivity rates here in New York have been off the charts. Some report that
5:15 Speaker 03 half of all Europeans will eventually be infected. China is locking down entire cities again. How much should we all be hunkering down?
5:25 Speaker 02 Yes, perennial question. It keeps coming back and we keep reacting to events rather than being ahead of them. And too often, I'm afraid, in the pandemic, we've thought, we've seen the worst and we're through it now and we'll have Freedom Day and, you know, it comes back to bite us. A degree of humility, I think, is really crucial. We're only two years into this pandemic and this will not be the last variant. I'm sure we will see more. There's a lot of good news, in a sense. The vaccines continue to be incredibly good at protecting you from getting severely ill and dying. That's hugely positive. So there is a lot of good news and a lot of progress, but the transmission of this Omicron variant is staggering. In London, around New Year, it got to one in nine, one in 10 people infected.
6:06 Speaker 02 I've never seen anything like that in my whole career. We've got to be hopeful that with that very high transmission, we will gain some degree of immunity. So maybe Omicron is the turning point, when we start to see some light at the end of the tunnel of this pandemic.
6:22 Speaker 03 And when you say we're only two years into the pandemic, it sort of sounds from you like, this is just going to continue, that in some ways, COVID-19 will become endemic in the way influenza is endemic?
6:35 Speaker 02 Yeah, it's not going away. This is now part of humanity and the next generations will still be talking about Omicron. I don't really like the comparisons with influenza. I think it's a little bit too simplistic to say it'll become like influenza. I think we've got quite a while to go before that will be true. This is happening all over the world at more or less the same time. That's seven billion people being infected on a cycle of waves. And that, of course, raises the possibility that there'll be new variants. We're not going to wake up one Tuesday morning and somebody will say the pandemic's over. It's not going to happen like that. It'll be a bumpy ride through 22 and into 23 and beyond.
7:14 Speaker 03 A lot of the folks who listen to this show are business people like yourself, running large organizations. One of the challenges is how do you plan when you really don't know what's going to be happening next? With this particular variant, do we have a sense of what the trajectory is going to be like and how we plan around it?
7:35 Speaker 02 Many people have got used to the concept of R, how transmissible something is. The natural R of this infection may be nine, 10 or 11. If you think the original strain from China had an R of three, you can see that's a massive difference. One of the results of that is that the upswing of the pandemic wave will be very fast. This started in November and before the end of December, this had spread to the whole world. My guess is that this pandemic wave will come down fast as well. And actually, we've seen that in London. We've hit peak within less than a month in London and it's already starting to come down. I think we're already starting to see that in New York. We're probably hitting peak and it's starting to come down. So I think this particular wave will go up quicker,
8:18 Speaker 02 reach peak quicker, and will come down the other side quicker and will get back to lower levels of transmission quicker than we have done perhaps with some of the other variants. But your comment about how do we deal with uncertainty, I think, is at the heart of this. And every organization is going to be different. I think the world has become much better at handling that uncertainty. I think actually many companies, individuals, families have become pretty good, pretty sophisticated at judging their own risk and changing their Behavior dependent on what they perceive the risk to be. And actually, I think people's behavior has changed ahead of where government policy has often been. And that's to be applauded. The way I think about this is, is what is the most likely scenario for the next one, two, three years?
9:00 Speaker 02 And probably based my decision making around that scenario. But then perhaps quieter and in more in the background think, what are the other possibilities? What do we need to prepare for on the downside that would really dramatically change the way we do business? And what can we prepare for on the upside and have a contingency set of options that get us ahead of our thinking? So that we're not always reactive, but we're starting to be proactive. We know what we would do in certain scenarios. And there aren't a hundred scenarios. There's probably five or six reasonable ones. And I, I think organizations can get their head around that sort of number.
9:37 Speaker 03 You're asked so often to give advice on imperfect information. In this time, you know, things changing, advice shifting, things getting updated, which can undercut trust. In messaging, is there an impulse to be more conservative about how you describe what things are? So people are more likely to be surprised with good news than bad news. How do you walk that line?
10:03 Speaker 02 Communicating uncertainty is really very, very difficult. But there have been, I think, good people that have stepped forward. And we watch people like Tony Fauci in the United States communicating, I think, very clearly. The key to me, as I watch others doing it, is the humility that comes with being willing and courageous enough to say, I don't know. These are the possible outcomes that we face from here on in. And there are some that we can't predict. I think the transparency of that is the best way forward. You know, I think people have got used to that sort of communication style now, appreciating that nobody's got a crystal ball. But the range of scenarios is possible to play out. Take Omicron, for example. I mean, it would not be right to say, nobody predicted it.
10:47 Speaker 02 Many people predicted we would see more variants. I've said already on this program that I think there'll be more variants. What the nature of those variants are, we can't predict. We can't predict when it'll happen or where it'll come from. But I think we have to be prepared that Omicron will not be the last variant, for instance.
11:05 Speaker 03 You mentioned Tony Fauci. On these shores, you're sometimes referred to as the Tony Fauci of the UK. Do you and he talk with each other?
11:15 Speaker 02 Tony won't be very pleased with that analogy, I'm sure, but it's a privilege to be associated with Tony. I've known him for many, many years, going back to SARS one and bird flu in Southeast Asia. And obviously, he's an icon of scientific endeavour. You know, he's not just a communications guru, he's also a brilliant scientist and a fantastic leader. And I think the US has been frankly, very lucky to have him. And the fact that he's stayed around and been through some tough times, that's a real tribute. And I haven't spoken to Tony since before Christmas, but I'm sure I will do later this month, and I look forward to that. But he's faced some really tough times in the US, I think. And it's a huge respect to watch the way he goes about what he does.
11:52 Speaker 03 Yeah, he was talking recently about the threats he receives, which is that a concern you have?
11:59 Speaker 02 Yes. I mean, when you and your team kindly sent me this microphone that I'm speaking to at the moment, it came in what looked like a bulletproof box with a customs thing that said wires and things. And actually, I have received both hate mail, death threats by mail, by email, by social media. And we've received some very odd packages that have come to the house. So actually, I contacted the security forces here when your microphone arrived and asked them to scan it and look at it properly before I opened it. You know, I think many, many people have had horrible abuse, but also physical threats. And Tony's certainly been one of those. And so have I here in the UK.
12:42 Speaker 03 You were a member of the UK's Scientific Advisory Group for Emergencies, SAGE, and you resigned late last year. Were these sorts of threats, any part of the motivation behind that?
12:56 Speaker 02 No, they weren't. No, they genuinely were not. The reason I stepped away from SAGE, I mean, SAGE was in place for, you know, 18 months. And the amount of work that goes into those SAGE meetings is enormous. And in September, October of 2021, I felt largely the work of SAGE had been done, that the advice from within the government system was now very strong, and the need for independent members on SAGE had become less. So it was a good time to step away.
13:23 Speaker 03 Well, one of your colleagues said to me that you're pretty even keeled, but that even he's had some harder moments during all this. And I'm curious what you found to be the hardest moments. Is it about the volume of work, as you're referring to?
13:39 Speaker 02 For everybody, particularly those, of course, in the health systems around the world, the volume, the strain on systems has been astonishing. And because of the worldwide nature of this as well, issues in Asia, issues on the West Coast of America, issues here in Europe and in Africa, the day has been stretched to meet with those time zones. So, you know, there are times when you've been on calls at four, five o'clock in the morning. So just the sheer volume has been staggering. But then also the combination of very many different activities from, yes, running your own organization as a chief executive, then as an advisor, then as a scientist as well, as well as then contributing World Health Organization, international agencies, World Bank and things. So it's the being pulled in multiple different directions that I think has took a while
14:23 Speaker 02 to get used to. I'm fortunate, you know, have a fantastic team at work who can take a lot of the burden and share that burden with me. So, you know, without a great team with you, I just don't think it would be possible.
14:37 Speaker 03 You've said we need to move faster than the pandemic. But at the same time, as you talk about it, like this crisis is a marathon, it just keeps going, right? So it's almost like we have to learn how to sprint nonstop.
14:51 Speaker 02 We do. In the last two years, we've been too slow and we've been too reactive. There has not perhaps been sufficient stepping back from the chaos and saying, you know, what are the possible scenarios and how would we deal with those if they came to pass? And so we sort of, if you like, get ahead of the pandemic rather than chasing it. And then I think, and I understand the reasons for this politically, there's a strong desire in many quarters through 21 to start saying we're through it. In the UK, we had Freedom Day. I think it would be better to change that narrative around getting people used to the fact that this is not just going to disappear, that we can certainly mitigate and reduce the true impact of it on health and education and trade and travel and economies. But we are going to have to learn to come to terms with it.
15:37 Speaker 03 People often think about philanthropy as being a bit stodgy. You've argued that in science, the role of philanthropy is to be disruptive, to take more risk. Can you explain that?
15:52 Speaker 02 Philanthropy, I think,'s role is not to be conservative, in a sense. Philanthropy can't ever be at the scale of government, and it cannot either be at the scale, actually, in truth, of industry. Philanthropy's role, I think, is to be catalytic, to take risks that inevitably taxpayers' money would struggle to fund. And parts of industry, certainly big industry, would struggle to fund as well. But I think that is a critical role for philanthropy, experimenting, taking risks. Recently, at Welcome, we set up the Welcome Leap to look at science in a different way, to fund it in a different way, to do it at a speed and a scale that was far faster than philanthropy often works. And again, it's an experiment. We'll see in a few years' time whether it's been successful in disrupting the way we look at science.
16:38 Speaker 03 There's talk in government and in business about investment in science, but if it doesn't pay off, it's often looked at as waste, right? As like you've missed. And that can be chilling, both for government to invest in things and for investors to take a run at things. Whereas I guess you have the freedom to explore.
16:58 Speaker 02 I think that sense that if something doesn't work, it's failed, has become far too pervasive in science funding. You actually don't know if something's failed for decades. Take the RNA technology that we're now, you know, most of the United States is vaccinated with an RNA vaccine. That hasn't developed overnight. That builds off years of work, much of it painstaking. If you looked at it five years ago, you might say it was failing. And yet here, it's saved humanity.
17:29 Speaker 00 We all know the disappointment that comes when a grand gesture falls flat, something that seemed impressive in the moment but didn't deliver the results you expected. Marketing budgets too often fall into that trap, aiming for big impressions, big reach, but without the revenue to back it. LinkedIn has a name for it: Bullspend. LinkedIn Ads generate the highest ROAS of all major ad networks. They target by company, industry, job title, and more. Spend $250 on your first campaign on LinkedIn Ads and get a $250 credit for the next one. Just go to LinkedIn.com/scale. That's LinkedIn.com/scale. Terms and conditions apply.
18:13 Speaker 00 When you've built substantial wealth through your business, it's often tied up in a single equity position. The upside is real, but so is the risk, and knowing when to act isn't always obvious. Creative Planning works with business owners to build a strategy around concentrated equity, when to diversify, how to manage tax risk, and how to protect what you've spent years building. Creative Planning: where wealth works together. Learn more at creativeplanning.com/mastersofscale. Stripe Treasury is your new financial operating system built for what's next. With Stripe Treasury, the place your business accepts payments is also where you can store balances, move funds, and pay vendors worldwide. If you're building for global scale,
18:58 Speaker 00 get a business bank account that lets your money move instantly, whenever and wherever you need it. Learn more at stripe.com/treasury. Stripe is not a bank. Banking services provided by Fifth Third Bank, National Association Member, FDIC.
19:15 Speaker 03 Before the break, we heard Sir Jeremy Farrar of Welcome talk about what Omicron means for the course of the pandemic, his relationship with Tony Fauci, and the need to take what he calls catalytic risks. Now he talks about the huge role that business has played and needs to keep playing in leading COVID response. He describes what he calls "second and third generation vaccines still to come", and talks about the two most important leadership lessons he's learned during the pandemic. And he makes a plea for all of us to say "never again", and to push for the necessary reform to make that a reality. So at Welcome, you're implementing a new strategy in your giving, more focused around three core topics:
19:58 Speaker 03 infectious diseases, climate change, and mental health. But my understanding is this was a strategy that was conceived before the pandemic. How have your priorities and operations at Welcome shifted as a result of going through what we've been through in the last two years?
20:15 Speaker 02 Yeah, they were formulated before the pandemic, but actually, if anything, the pandemic experience of the last two years has reinforced the reasons for the change. One of the hardest things is to bring about the critique of yourself. I feel very, very strongly. You need to reform and change when you perhaps least feel the need to do it. Change when you're comfortable. Change when you think you're strong, rather than react and have to change when others demand it of you. And really, at the heart of the strategy was to say, how can we make our biggest contribution to society? And I felt that was by being really catalytic and risk-taking in the discovery science. And then to focus on three things, which I think are going to define the 21st century.
20:58 Speaker 02 Climate's obviously the existential threat we face in the 21st century. Infectious diseases are not going away. Pandemics will continue. And then I think mental health has perhaps the one area of medicine that has made some of the less progress over the last 20, 30 years. And I think particularly young people's mental health is a huge and growing problem.
21:18 Speaker 03 They sound like areas that you might have come to today, based on what we've experienced in the last two years.
21:24 Speaker 02 The pandemic was not on our agenda when we developed these four areas, but I think you're right. They do come together in a sharper focus as a result of the pandemic. And very importantly for us, they will, I think, have a disproportionate impact on young people. They'll have a disproportionate impact on people marginalized in any community and in the most vulnerable.
21:44 Speaker 03 In the last two years, in your leadership role, are there new lessons that you've learned? Anything your perspective has shifted on that you maybe didn't appreciate the same way, or maybe has been reinforced in new ways?
22:02 Speaker 02 Yeah, many, the importance of finding time for yourself, in a sense, protecting yourself, finding space to retreat to in a way. I found great regeneration, if you like, by playing sport, by playing cricket, which I appreciate nobody on this call will perhaps understand, but I take great joy in it. Others will go and play a musical instrument or go to a gallery or something. But I think finding space where you can clear your head, where you can stop and think, where you can just buy yourself that little bit of time for yourself, actually, or your loved ones, I think is so important. So that would be one key lesson for me. And the second is take warnings seriously. Covid nineteen did not come out of the blue. Over the last twenty years, we've had repeated warnings, going
22:47 Speaker 02 back to SARS one and work I was involved in in Southeast Asia with bird flu and Zika and MERS and many, many other Ebola, of course. Take these warnings seriously. And I think at a time of where politics has become very short term, where the key issue is the midterm elections or the next election, you're everyone's on a two to four year cycle at most, if not the twenty four hour news cycle. Really important to stand back. What do we want in the twenty first century? And what are we going to have to do to invest over the long term?
23:18 Speaker 03 In your book, In Spike, it references both the incredible scientific advances during this time and the challenges in coalescing global efforts for good. As we look for silver linings from this tragedy, how does that net out? Like, are you optimistic? Are you worried?
23:42 Speaker 02 So I'm optimistic because I think on the whole, in the end, humanity historically has ended up in pretty good places. The trouble is humanity often finds ways of going through some really bad periods to get to the good place. And I think we're going through a bad period at the moment. The geopolitics is part of the pandemic, I'm afraid. It goes back to where the virus came from and the way that was handled at the start and the blame game that was associated with it. And it's panning out now in the way that The United Nations, the World Bank, the WHO can function, the G seven and G twenty agencies. And we really need these organizations in the 21st century. Because if you look at the great challenges, climate change, infection, migration,
24:26 Speaker 02 access to good energy, clean energy, water, whatever we think of the great challenges of the 21st century, they are all transnational. You cannot find a solution to these problems just in America, just in the UK, just in China, just in India. You are going to be dependent on what your neighbors do. And so until we can see that our national boundaries are not going to suffice to address our great challenges, then I think we're going to make some very major errors and mistakes. And I think the pandemic has again brought that into focus and we've got to learn, in my view, that lesson.
25:02 Speaker 03 Within Welcome, you guys invest in so much forward looking research. I'm curious whether there's any research that you're most excited about.
25:12 Speaker 02 Yeah, huge number. It starts with discovery. I do think curiosity, basic so-called basic science, whether it's biomedical or social sciences, I think is the bedrock of future advances. Very excited by all of the work over the last 20, 30 years on genomics and genetics. And now that's starting to translate into patient benefit and population benefit. I thought the recent work from DeepMind on working out protein structures from genetic sequences was groundbreaking. In the more translational areas, I think work on the malaria vaccine and the tuberculosis vaccine that is coming now could transform the lives of people everywhere.
25:51 Speaker 02 What I'd love to see, I hope this comes, is similar developments that we've seen in cancer and diabetic care coming into mental health, both at the senior people, obviously with Alzheimer's and dementia, but then the anxiety and depression and other illnesses of mental health that start in young people. It hasn't seen the same advances. And I think we've got to try and create a community that will bring the various bits of science and prevention together to make a real difference in mental health.
26:22 Speaker 03 We've mentioned vaccines a couple of times. You know, we've seen these so-called Omicron boosters announced by Moderna and Pfizer. They could be ready by the spring. Are these kind of targeted, single variant approaches the future? Like, I'm going to be getting lots of different shots of lots of different kinds?
26:41 Speaker 02 No, I think they're the short-term future. I think the first-generation vaccines, the ones I've had and I hope you've had, are what I call first-generation vaccines. Incredibly safe, highly effective at stopping you getting sick or going to hospital. The second-generation vaccines are, I think, the variant-specific, Omicron-specific vaccines, and they'll come very quickly in 2022. Then I think the next step will be multivalent vaccines. So you get a broader immune response to maybe two or three different variants within a single vaccine, a bit like we do for influenza. What I'm really excited by is what I call third-generation vaccines. So vaccines that will be against all coronaviruses, vaccines that'll stop transmission
27:25 Speaker 02 as well as stopping illness and sickness, and vaccines that won't have to be given every three or four or six months, but we could take and would give us long-term protection for hopefully many, many years to come. And that's what I think we need to be investing in now, so that at some point in the 2020 decade, we have vaccines which are long-lasting, cheap to produce around the world, accessible to everybody, and which protect us not just against COVID-19, but against any coronavirus that may come in the future.
27:56 Speaker 03 What's at stake for Welcome right now?
28:02 Speaker 02 We have an endowment that was left to us by Henry Welcome and Americans. So we've always been very grateful to America for sending Henry Welcome to us. I think COVID has demonstrated how dangerous it is to have such an unequal world. Throughout history, I think, when we've had such unequal, inequitable worlds, it's led to conflict, and I think we need to avoid that. So being edgy, being disruptive, funding great science, but also translating that science to patient and population benefit the world over, that's what's at stake. And on that, I'm very optimistic.
28:36 Speaker 03 I mentioned earlier that a lot of our listeners are business people. What's the role of business in addressing public health versus that of government or even of philanthropies like Welcome?
28:50 Speaker 02 Huge role and multifaceted. The Edelman Trust Index, if you look at that, it's clear that many, many people trust their employer. Many people entrust the people they work with, even more so maybe than governments. And so I think organizations and companies have got a really critical role to play in providing information. And yes, indeed, when necessary, services to their workforce. Inevitably, government cannot provide everything. And largely through the pandemic, I think companies have really stepped up and provided that sort of additional level of information and support. I think we could push that even further. For instance, workforce, mental health, providing a good working environment, which puts wellness at the heart of it.
29:32 Speaker 02 It is something that I think all good employers will increasingly have to build into the offer they make to their staff.
29:38 Speaker 03 You have a very nice way of delivering, you know, some hard information in ways that sound like they're upbeat. But, you know, we need to make some steps, right?
29:49 Speaker 02 We do. I just came off another call with the high level panel that's been advising the G20 process. Leadership in organizations and companies, I think actually on the main, I think that has been very good. We need political leadership. We need political leadership that will say never again. When you face a crisis like this, and obviously going back to the 20th century, we faced some crises. It was always after those crises that reforms happened, that change happened, that political leaders stepped up and said, never again. And I think we need that now, and we need to bring the world back together again. And, and I suppose my one plea for the next few months, weeks, years would be for that political leadership.
30:28 Speaker 02 Philanthropy can do something, companies can do something, but in the end, it's political leadership that is needed to at least frame how things work. Even if it doesn't necessarily do everything within that.
30:40 Speaker 03 Well, Jeremy, that's great. And thank you so much for taking the time to talk with us and with our audience. Really appreciate it.
30:48 Speaker 02 Oh, it's been a great pleasure. Thanks very much indeed.
30:52 Speaker 00 Global hiring is such a headache when you're building fast, but don't let payroll, compliance, or onboarding slow you down. Companies like Eleven Labs and Mistral are scaling globally and effortlessly with Deal. Eleven Labs quadrupled their headcount in 2025, and Mistral pays 364 employees across 15 countries, all from one system. Build your global team with Deal. Visit deal.com/mos and start expanding your business today. That's D E E L dot com slash M O S.
31:29 Speaker 00 Before we get to the rest of our conversation today, I want to spend a moment sharing with you about Masters of Scale Summit, which returns to San Francisco this October 20th to 22nd. So many of us feel overwhelmed right now. It feels like so much of the world is careening, and we don't have power, we don't have agency. That's the thing about the Masters of Scale Summit. It's really designed to remind us that we do have agency, agency to lead, agency to design, to build the relationships and the partnerships that empower us and to make the change that we want to see. We program a stage, we curate an audience, we set a schedule that builds in time for these relationships to be made and to grow so that by the time you leave Summit,
32:13 Speaker 00 you are fired out of a cannon, ready to run through walls to do better in the world with the agency that you actually have. I hope to see you there. Visit mastersofscale.com/summit.
32:31 Speaker 00 Every business hits the same wall the moment your business outgrows the systems that got you here. Spreadsheets everywhere, five different logins, data scattered across entities that don't even talk to each other. If your finance team spends more time finding data than using it, that's when you need the Intuit ERP. Intuit Enterprise Suite is the AI-native ERP solution that's powerful, painless, and proven, built for businesses scaling fast without the complexity that usually comes with it. From the makers of QuickBooks, learn more at intuit.com/ERP.
33:12 Speaker 03 Masters of Scale Rapid Response is a Wait What original. The show is recorded remotely using sanitized audio gear. I'm your Rapid Response host, Bob Safi, and host for Masters of Scale is Reid Hoffman. Our executive producers are June Cohen and Darren Triff. Our supervising producer is Jay Punjabi. Our producers are Jordan McLeod, Christina Gonzalez, and Marie McCoy Thompson. Our music director is Ryan Holiday. Original music and sound design by Daniel Nissenbaum and the Holiday Brothers. Audio editing by Keith J. Nelson, Stephen Davies, Andrew Knall, and Mike Gallagher. Mixing and mastering by Aaron Bastinelli. Special thanks to Emily McManus, Sarah Sandman, Kelsey Capitano, Tim Cronin, Charlie
33:56 Speaker 03 Menezes, Adam Heiner, Anna Pizzino, Ben Richardson, Mina Kurosawa, Said Asafiaba, and Colin Howard. Become a member of Masters of Scale to get access to a year's worth of courses and content on the Masters of Scale Courses app. Find out more at mastersofscale.com/membership. Visit mastersofscale.com/rapidresponse to find the transcript for this episode and be sure to subscribe to our email newsletter.
34:31 Speaker 03 Hey listeners, Bob here. If you listen to Rapid Response on Masters of Scale, you may be missing half the show because every Friday we release a second Rapid Response exclusively in the Rapid Response feed. The guests and topics are just as compelling and timely, from Ford CEO to NASA's administrator to the lessons from the devil wears Prada. It takes about 10 seconds to find. Just search Rapid Response wherever you listen to podcasts and hit follow to make sure you never miss an episode. I hope to see you there.
Previous Always be recruiting, w/Paul English, co-founder of Kayak Next The 4 core principles of crisis management, w/Ellen Kullman (DuPont, Carbon) Page updated October 26, 2026 · transcript and summary are machine-generated